p38γ Mitogen-Activated Protein Kinase Contributes to Oncogenic Properties Maintenance and Resistance to Poly (ADP-Ribose)-Polymerase-1 Inhibition in Breast Cancer

Cuenda, 2007, p38 MAP-kinases pathway regulation, function and role in human diseases, Biochim Biophys Acta, 1773, 1358, 10.1016/j.bbamcr.2007.03.010 Dhanasekaran, 2007, MAPKs: function, regulation, role in cancer and therapeutic targeting, Oncogene, 26, 3097, 10.1038/sj.onc.1210395 Goedert, 1997, Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases, EMBO J, 16, 3563, 10.1093/emboj/16.12.3563 Han, 1994, A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells, Science, 265, 808, 10.1126/science.7914033 Jiang, 1996, Characterization of the structure and function of a new mitogen-activated protein kinase (p38β), J Biol Chem, 271, 17920, 10.1074/jbc.271.30.17920 Jiang, 1997, Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ, J Biol Chem, 272, 30122, 10.1074/jbc.272.48.30122 Lechner, 1996, ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation, Proc Natl Acad Sci USA, 93, 4355, 10.1073/pnas.93.9.4355 Freshney, 1994, Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27, Cell, 78, 1039, 10.1016/0092-8674(94)90278-X Rouse, 1994, A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins, Cell, 78, 1027, 10.1016/0092-8674(94)90277-1 Conrad, 1999, Selective activation of p38α and p38γ by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells, J Biol Chem, 274, 23570, 10.1074/jbc.274.33.23570 Pramanik, 2003, p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity, J Biol Chem, 278, 4831, 10.1074/jbc.M207732200 Wang, 2002, Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38α and p38δ MAPK isoforms by TGF-β1 in murine mesangial cells, J Biol Chem, 277, 47257, 10.1074/jbc.M208573200 Li, 1996, The primary structure of p38γ: a new member of p38 group of MAP kinases, Biochem Biophys Res Commun, 228, 334, 10.1006/bbrc.1996.1662 Abdollahi, 2003, Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3, Cancer Res, 63, 4521 Liu, 2003, Gene expression profiles of hepatoma cell line HLE, World J Gastroenterol, 9, 683, 10.3748/wjg.v9.i4.683 Tang, 2005, Essential role of p38γ in K-Ras transformation independent of phosphorylation, J Biol Chem, 280, 23910, 10.1074/jbc.M500699200 Wang, 2000, Involvement of the MKK6-p38γ cascade in γ-radiation-induced cell cycle arrest, Mol Cell Biol, 20, 4543, 10.1128/MCB.20.13.4543-4552.2000 Sakabe, 2002, Potent transforming activity of the small GTP-binding protein Rit in NIH 3T3 cells: evidence for a role of a p38γ-dependent signaling pathway, FEBS Lett, 511, 15, 10.1016/S0014-5793(01)03264-1 Qi, 2006, p38γ mitogen-activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasion, Cancer Res, 66, 7540, 10.1158/0008-5472.CAN-05-4639 Loesch, 2010, p38γ MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9, J Biol Chem, 285, 15149, 10.1074/jbc.M110.105429 Kwong, 2009, p38α and p38γ mediate oncogenic ras-induced senescence through differential mechanisms, J Biol Chem, 284, 11237, 10.1074/jbc.M808327200 Aslakson, 1992, Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor, Cancer Res, 52, 1399 Morel, 2008, Generation of breast cancer stem cells through epithelial-mesenchymal transition, PLoS One, 3, e2888, 10.1371/journal.pone.0002888 Mani, 2007, Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers, Proc Natl Acad Sci USA, 104, 10069, 10.1073/pnas.0703900104 Zhang, 2010, Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo, Cancer Res, 70, 3996, 10.1158/0008-5472.CAN-09-3752 Zhang, 2008, Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells, Breast Cancer Res Treat, 112, 217, 10.1007/s10549-007-9847-6 Hu, 2009, MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer, Cancer Cell, 15, 9, 10.1016/j.ccr.2008.11.013 Su, 2010, Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway, Int J Cancer, 127, 555, 10.1002/ijc.25083 Zhuo, 2008, Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway, Biochem Biophys Res Commun, 369, 1098, 10.1016/j.bbrc.2008.02.143 Bryant, 2005, Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase, Nature, 434, 913, 10.1038/nature03443 Farmer, 2005, Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy, Nature, 434, 917, 10.1038/nature03445 Fong, 2010, Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval, J Clin Oncol, 28, 2512, 10.1200/JCO.2009.26.9589 Engelman, 2009, Targeting PI3K signalling in cancer: opportunities, challenges and limitations, Nat Rev Cancer, 9, 550, 10.1038/nrc2664 O'Reilly, 2006, mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt, Cancer Res, 66, 1500, 10.1158/0008-5472.CAN-05-2925 Wu, 2010, Recent progress in phosphoinositide 3-kinases: oncogenic properties and prognostic and therapeutic implications, Curr Protein Pept Sci, 11, 425, 10.2174/138920310791824156 Engelman, 2008, Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers, Nat Med, 14, 1351, 10.1038/nm.1890 McCabe, 2006, Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition, Cancer Res, 66, 8109, 10.1158/0008-5472.CAN-06-0140 Moynahan, 1999, Brca1 controls homologydirected DNA repair, Mol Cell, 4, 511, 10.1016/S1097-2765(00)80202-6 Tutt, 2001, Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences, EMBO J, 20, 4704, 10.1093/emboj/20.17.4704 Miyoshi, 2008, Basal-like subtype and BRCA1 dysfunction in breast cancers, Int J Clin Oncol, 13, 395, 10.1007/s10147-008-0831-x Rakha, 2008, Basal-like breast cancer: a critical review, J Clin Oncol, 26, 2568, 10.1200/JCO.2007.13.1748 Tischkowitz, 2006, The basal phenotype of BRCA1-related breast cancer: past, present and future, Cell Cycle, 5, 963, 10.4161/cc.5.9.2713 Jaspers, 2009, Therapeutic options for triple-negative breast cancers with defective homologous recombination, Biochim Biophys Acta, 1796, 266 Turner, 2008, A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor, EMBO J, 27, 1368, 10.1038/emboj.2008.61